TSH Biopharm Corporation Limited (TPEX:8432)

TSH Biopharm Corporation Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	588.64	588.34	576.59	488.9	381.89	396.7
Short-Term Investments	325.88	309.02	195.54	326.86	351.52	328.97
Cash & Short-Term Investments	914.52	897.36	772.12	815.77	733.41	725.67
Cash Growth	12.85%	16.22%	-5.35%	11.23%	1.07%	6.31%
Accounts Receivable	358.98	211.68	208.33	202.55	99.07	108.88
Other Receivables	3.3	2.39	2.18	1.83	1.06	2.98
Receivables	362.29	214.07	210.51	204.38	100.13	111.86
Inventory	192.46	176.08	118.4	107.39	73.22	77.91
Prepaid Expenses	5.4	16.79	9.29	-	-	-
Other Current Assets	2.15	0.41	3.44	15.37	13.22	28.41
Total Current Assets	1,477	1,305	1,114	1,143	919.97	943.84
Property, Plant & Equipment	36.93	40.41	32.68	41.64	27.36	34.04
Long-Term Investments	190.33	192.63	188.89	179.08	212.06	241.43
Goodwill	247.9	247.9	-	-	-	-
Other Intangible Assets	44.2	39.75	53.64	64.07	3.63	6.18
Long-Term Deferred Tax Assets	4.01	4.01	1.51	1.8	2.01	1.26
Other Long-Term Assets	19.03	12.78	9.39	5.62	4.39	2.64
Total Assets	2,019	1,842	1,400	1,435	1,169	1,229
Accounts Payable	176.84	71.36	51.42	57.64	12.72	7.42
Accrued Expenses	51.55	56.69	35.21	37.4	44.77	48.8
Short-Term Debt	-	-	-	20	-	-
Current Portion of Long-Term Debt	-	-	-	18.85	-	-
Current Portion of Leases	10.84	10.1	7.4	7.32	4.57	4.37
Current Income Taxes Payable	21.15	32.23	2.97	8.02	7.1	15.65
Current Unearned Revenue	1.86	1.04	1.84	5.43	-	-
Other Current Liabilities	47.51	37.48	34.79	50.85	16.64	22.39
Total Current Liabilities	309.74	208.9	133.63	205.5	85.8	98.62
Long-Term Debt	-	-	-	9.6	-	-
Long-Term Leases	8.08	10.33	-	7.36	-	4.42
Total Liabilities	317.81	219.23	133.63	222.46	85.8	103.04
Common Stock	383.98	383.98	383.98	383.98	383.98	383.98
Additional Paid-In Capital	459.61	459.55	459.5	459.44	459.36	458.98
Retained Earnings	514.69	480.68	204.14	228.37	224.08	266.63
Comprehensive Income & Other	83.75	67.58	59.98	22.58	16.21	16.76
Total Common Equity	1,442	1,392	1,108	1,094	1,084	1,126
Minority Interest	259.37	231.18	158.63	118.31	-	-
Shareholders' Equity	1,701	1,623	1,266	1,213	1,084	1,126
Total Liabilities & Equity	2,019	1,842	1,400	1,435	1,169	1,229
Total Debt	18.91	20.43	7.4	63.13	4.57	8.78
Net Cash (Debt)	895.61	876.93	764.73	752.64	728.84	716.89
Net Cash Growth	12.28%	14.67%	1.60%	3.27%	1.67%	5.68%
Net Cash Per Share	23.28	22.81	19.90	19.57	18.96	18.65
Filing Date Shares Outstanding	38.4	38.4	38.4	38.4	38.4	38.4
Total Common Shares Outstanding	38.4	38.4	38.4	38.4	38.4	38.4
Working Capital	1,167	1,096	980.13	937.41	834.17	845.22
Book Value Per Share	37.55	36.25	28.85	28.50	28.22	29.33
Tangible Book Value	1,150	1,104	1,054	1,030	1,080	1,120
Tangible Book Value Per Share	29.95	28.76	27.45	26.83	28.13	29.17
Land	5.85	5.85	5.85	5.85	5.85	5.85
Buildings	14.2	14.2	14.2	13.94	13.94	13.94
Machinery	48.55	47.68	33.13	31.41	22.48	22.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.